A Randomized Phase II/III Study of Conventional Chemotherapy Plus or Minus Uproleselan in Older Adults with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy (A041701)

A Randomized Phase II/III Study of Conventional Chemotherapy Plus or Minus Uproleselan in Older Adults with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy (A041701)

Trial Category:
Hematologic
Contact(s)
Mary Beth Wilwerding, RN
Phone
402-991-8070
Fax
402-991-8850
Location(s)
Methodist Estabrook Cancer Center, Omaha, NE
 
 
Become a NOS Member Today!
 

Platinum Corporate Members

Gold Corporate Members